MFG
GILD icon

Magnus Financial Group’s Gilead Sciences GILD Stock Holding History

Magnus Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,078
Closed -$321K – 371
2020
Q3 		$321K Sell
5,078
-5,578
-52% -$387K 0.04% 182
2020
Q2 		$820K Buy
10,656
+230
+2% +$17.6K 0.09% 89
2020
Q1 		$779K Buy
10,426
+6,515
+167% +$450K 0.11% 95
2019
Q4 		$254K Buy
3,911
+21
+0.5% +$1.37K 0.04% 380
2019
Q3 		$247K Buy
3,890
+33
+0.9% +$2.16K 0.05% 351
2019
Q2 		$261K Buy
+3,857
New +$254K 0.05% 327

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Magnus Financial Group's GILD Position: Q4 2020 in Review

Magnus Financial Group sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 5,078 shares — an estimated $321K sold.

Magnus Financial Group first reported a position in GILD in Q2 2019 and held it in 6 quarters. The position peaked at $820K in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Magnus Financial Group reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Magnus Financial Group sold 5,078 Gilead Sciences shares in Q4 2020, an estimated $321K.
  • Magnus Financial Group first reported a position in Gilead Sciences in Q2 2019 and held it in 6 quarters.
  • Magnus Financial Group's Gilead Sciences position peaked at $820K in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Magnus Financial Group's 13F filing for Q4 2020, filed 5 Feb 2021.